Theresa Wingrove is VP at ImmunoGen, Inc. (IMGN). They have made 5 open-market trades across 1 company since 2014, most recently 2024-02-12.
CIK 0001510720
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IMGN | 21,039 | $657K |
Shares reported on the most recent Form 4, priced at the 2024-02-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMGN | SELL · 10b5-1 | 2024-02-05 | 2024-02-06 | $29.30 | $705K | N/A | N/A | N/A |
| IMGN | SELL · 10b5-1 | 2024-01-16 | 2024-01-18 | $29.64 | $11.1M | -0.6% | N/A | N/A |
| IMGN | SELL · 10b5-1 | 2023-12-15 | 2023-12-19 | $29.40 | $3.5M | -0.0% | -0.5% | N/A |
| IMGN | SELL · 10b5-1 | 2023-11-29 | 2023-12-01 | $28.46 | $9.7M | +2.9% | +1.9% | N/A |
| IMGN | SELL · 10b5-1 | 2023-11-15 | 2023-11-17 | $15.85 | $5.3M | +87.4% | +88.2% | N/A |
| IMGN | SELL · 10b5-1 | 2023-11-07 | 2023-11-08 | $16.66 | $650K | -6.3% | +83.1% | +85.0% |
| IMGN | SELL | 2023-10-16 | 2023-10-18 | $14.40 | $5.5M | -4.6% | +9.4% | +101.3% |
| IMGN | SELL | 2023-09-15 | 2023-09-19 | $15.44 | $5.9M | +0.9% | -7.2% | +87.3% |
| IMGN | SELL | 2020-02-24 | 2020-02-25 | $4.99 | $161K | -12.9% | -26.4% | +1.4% |
| IMGN | SELL | 2018-02-22 | 2019-02-25 | $5.60 | $124K | -55.8% | -57.1% | -67.1% |
| IMGN | SELL | 2018-02-21 | 2018-02-23 | $10.88 | $248K | +3.9% | +15.5% | -5.6% |
| IMGN | SELL · 10b5-1 | 2014-01-10 | 2014-01-13 | $15.04 | $94K | -29.5% | -3.5% | -3.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.